These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18972703)

  • 1. The forgotten plague.
    Park A
    Time; 2008 Oct; 172(15):55-61. PubMed ID: 18972703
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tuberculosis in Somalia with consequences in Sweden].
    Winstrand A; Kulane A; von Schreeb J
    Lakartidningen; 2010 Dec; 107(51-52):3279-81. PubMed ID: 21294349
    [No Abstract]   [Full Text] [Related]  

  • 3. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 4. World tuberculosis control: how far have we to go?
    Enarson DA
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S219-23. PubMed ID: 11144556
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tuberculosis as an international and national problem].
    Khomenko AG
    Probl Tuberk; 1994; (2):2-4. PubMed ID: 8036208
    [No Abstract]   [Full Text] [Related]  

  • 6. The threat of extensively drug-resistant tuberculosis.
    Mohapatra PR
    Clin Infect Dis; 2007 Mar; 44(6):888-9. PubMed ID: 17304469
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tuberculosis--still increasing threat. Time for mobilization over the national borders].
    Larsson LO
    Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1882-3. PubMed ID: 19739439
    [No Abstract]   [Full Text] [Related]  

  • 8. MDR tuberculosis--critical steps for prevention and control.
    Nathanson E; Nunn P; Uplekar M; Floyd K; Jaramillo E; Lönnroth K; Weil D; Raviglione M
    N Engl J Med; 2010 Sep; 363(11):1050-8. PubMed ID: 20825317
    [No Abstract]   [Full Text] [Related]  

  • 9. New initiative to increase access to tuberculosis (TB) drugs.
    Nurs Ethics; 2001 May; 8(3):283-4. PubMed ID: 16010923
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis recommendations.
    Coker RJ
    Sex Transm Infect; 1998 Aug; 74(4):240-2. PubMed ID: 9924460
    [No Abstract]   [Full Text] [Related]  

  • 11. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
    Tärnvik A
    Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
    [No Abstract]   [Full Text] [Related]  

  • 12. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensively drug-resistant tuberculosis. Recent outbreaks highlight the need for improved prevention, control, and surveillance programs.
    Todd B
    Am J Nurs; 2007 Jun; 107(6):29-31. PubMed ID: 17519597
    [No Abstract]   [Full Text] [Related]  

  • 14. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis control: how the world has changed since 1990.
    Hopewell PC
    Bull World Health Organ; 2002; 80(6):427. PubMed ID: 12131995
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of pulmonary tuberculosis: shorter and with more potency].
    Broekmans JF; van Herwaarden CL
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2160-3. PubMed ID: 8984350
    [No Abstract]   [Full Text] [Related]  

  • 17. DOTS in Haiti.
    Ollé-Goig JE
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):282-3. PubMed ID: 10751080
    [No Abstract]   [Full Text] [Related]  

  • 18. Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
    Keshavjee S; Farmer PE
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1222-5. PubMed ID: 20843411
    [No Abstract]   [Full Text] [Related]  

  • 19. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps.
    O'Brien RJ; Nunn PP
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1055-8. PubMed ID: 11316634
    [No Abstract]   [Full Text] [Related]  

  • 20. From the Centers for Disease Control and Prevention. Tuberculosis treatment interruptions--Ivanovo Oblast, Russian Federation, 1999.
    JAMA; 2001 Apr; 285(15):1953-4. PubMed ID: 11336045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.